Ravgen’s mission is to provide state of the art genetic testing that will enrich the lives of its patients. Through noninvasive prenatal diagnostic tests, Ravgen gives patients the knowledge they need to prepare for their pregnancies and treat diseases at an early stage.
After several years of research Ravgen published its first paper in the Journal of the American Medical Association (JAMA) in 2004. The paper described how the company was able to increase the percentage of fetal DNA present in a tube of blood from the mother by adding the preservative, formaldehyde. In 2007, a second journal article was published in The Lancet which presented a study showcasing its ability to use this technology to detect Down’s syndrome from blood. These publications received worldwide press coverage, from CNN to The London Times and Washington Post.
How Our Review System Works?
- We look for Customers’ feedback on the various review websites and social platforms.
- Check Website’s Authenticity and Authority- (Google Page Rank, On-Page SEO Factors, Social Media Engagement)
- User Experience(UI)
- Look for the “S” in HTTPS
- Check for the website privacy policy
- Find their contact information
- Verify their trust seal
- Scan For malware on their website